Gavin Barlow

Gavin is a member of the Experimental Medicine and Biomedicine research group at Hull York Medical School.

Biomarker Driven Antifungal Stewardship (BioDriveAFS) in acute Leukaemia – a multi-centre randomised controlled trial to assess clinical and cost effectiveness: a study protocol for a randomised controlled trial
Flett, L. G., Abdelatif, R., Baz, S. A., Brady, S., Corbacho, B., Common, K., Cowling, A., Fairhurst, C. M., Fitzmaurice, E., Gandhi, S., Hilton, A., Hope, W., Howard, A., Laycock, J. L., Lillie, P., Mitchell, G., Parker, A., Peel, M., Sheard, L. & Sneddon, J. & 6 others, Taynton, T., Tharmanathan, P., Torgerson, D. J., Wang, H.-I., Allsup, D. & Barlow, G., 28 Jun 2024, In: Trials. 25, 427.
Research output: Contribution to journal › Article › peer-review

Open Access
File
How can we optimize antifungal use and stewardship in the treatment of acute leukemia?
Taynton, T., Allsup, D. & Barlow, G., 25 Jul 2024, (E-pub ahead of print) In: Expert review of hematology. 17, 9, p. 581-593 13 p.
Research output: Contribution to journal › Review article › peer-review

Open Access
File
Molecular antimicrobial susceptibility testing in sepsis
Martin-Loeches, I., Pereira, J. G., Teoh, T. K., Barlow, G., Dortet, L., Carrol, E. D., Olgemöller, U., Boyd, S. E. & Textoris, J., 5 Jan 2024, In: Future microbiology. 19, p. 61-72 12 p.
Research output: Contribution to journal › Review article › peer-review

Personal profile